Colon Surgery Risk With Corticosteroids Versus Immunomodulators or Biologics in Inflammatory Bowel Disease Patients With Clostridium difficile Infection.

MLA

Solanky, Dipesh, et al. “Colon Surgery Risk With Corticosteroids Versus Immunomodulators or Biologics in Inflammatory Bowel Disease Patients With Clostridium Difficile Infection.” Inflammatory Bowel Diseases, vol. 25, no. 3, Feb. 2019, pp. 610–19. EBSCOhost, https://doi.org/10.1093/ibd/izy291.

APA

Solanky, D., Pardi, D. S., Loftus, E. V., & Khanna, S. (2019). Colon Surgery Risk With Corticosteroids Versus Immunomodulators or Biologics in Inflammatory Bowel Disease Patients With Clostridium difficile Infection. Inflammatory Bowel Diseases, 25(3), 610–619. https://doi.org/10.1093/ibd/izy291

Chicago

Solanky, Dipesh, Darrell S Pardi, Edward V Loftus, and Sahil Khanna. 2019. “Colon Surgery Risk With Corticosteroids Versus Immunomodulators or Biologics in Inflammatory Bowel Disease Patients With Clostridium Difficile Infection.” Inflammatory Bowel Diseases 25 (3): 610–19. doi:10.1093/ibd/izy291.